Toggle navigation
Home
Search
Services
Blog
Contact
About
Controlling Uveitis with Nrts
Narducy, Kenneth W.
Centaur Pharmaceuticals, Inc., Sunnyvale, CA, United States
Search 16 grants from Kenneth Narducy
Search grants from Centaur Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Next-Generation Mouse Models of Endometrial Cancer
Protein kinase C-dependent inhibition of Kir channels
Diet Adherence Intervention for Dyslipidemia (Dietaid)
Inquiry-Based Environmental Science Using Stressed Stream Analysis
Resonance Light Scattering and the Study of Synthetic and Biological Light-Harvesting Systems
Recently added grants:
Functional Categorization of Ciliary Motion in PCD
Defining novel mechanisms for human arrhythmia
Neuroimmune Mechanisms Involved in the Pathogenesis of Hypertension and Renal Injury
Admin Core
Systems Mechanobiology Modeling for Patient-Specific Cardiac Fibrosis Predictions
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43EY011050-01A1
Application #
2165303
Study Section
Special Emphasis Panel (ZRG1-VISA (02))
Project Start
1996-05-01
Project End
1996-10-31
Budget Start
1996-05-01
Budget End
1996-10-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Centaur Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Sunnyvale
State
CA
Country
United States
Zip Code
94085
Comments
Be the first to comment on Kenneth Narducy's grant